Concomitant purification of prostatic carcinoma tumor markers from human seminal fluid under nondenaturing conditions

14Citations
Citations of this article
8Readers
Mendeley users who have this article in their library.

Abstract

We report a protocol for concomitant purification to homogeneity of both prostatic acid phosphatase [orthophosphoric-monoester phosphohydrolase (acid optimum), EC 3.1.3.2] and prostate-specific antigen, from human seminal fluid. The method requires only two chromatographic steps: passage through an Affigel-Blue column and gel filtration HPLC. This is a fast, efficient procedure for purification of these two important tumor markers, which are specific for prostatic cancer.

Cite

CITATION STYLE

APA

Rusciano, D., Berardi, A., Ceccarini, C., & Terrana, B. (1988). Concomitant purification of prostatic carcinoma tumor markers from human seminal fluid under nondenaturing conditions. Clinical Chemistry, 34(12), 2528–2532. https://doi.org/10.1093/clinchem/34.12.2528

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free